ヘルスケア分析/医療分析の世界市場予測（～2022年）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 MARKET SCOPE 27
1.3.1 MARKETS COVERED 27
1.3.2 GEOGRAPHIC SCOPE 28
1.3.3 YEARS CONSIDERED FOR THE STUDY 28
1.4 CURRENCY 28
1.5 LIMITATIONS 29
1.6 STAKEHOLDERS 29
2 RESEARCH METHODOLOGY 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Secondary sources 31
2.1.2 PRIMARY DATA 32
2.1.2.1 Primary sources 32
2.1.2.2 Breakdown of primary interviews: by company type, designation, and Region 33
2.1.2.3 Key industry insights 33
2.2 MARKET SIZE ESTIMATION 34
2.2.1 BOTTOM-UP APPROACH 34
2.2.2 TOP-DOWN APPROACH 35
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 36
2.4 ASSUMPTIONS FOR THE STUDY 37
3 EXECUTIVE SUMMARY 38
4 PREMIUM INSIGHTS 44
4.1 HEALTHCARE ANALYTICS: MARKET OVERVIEW 44
4.2 HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL 45
4.3 HEALTHCARE ANALYTICS MARKET, BY TYPE 45
4.4 ASIA HEALTHCARE ANALYTICS MARKET, BY APPLICATION 46
4.5 HEALTHCARE ANALYTICS MARKET, BY COMPONENT 47
4.6 HEALTHCARE ANALYTICS MARKET, BY END USER 47
4.7 GEOGRAPHIC SNAPSHOT OF THE HEALTHCARE ANALYTICS MARKET 48
 
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
5.2.1 DRIVERS 50
5.2.1.1 Implementation of government initiatives to increase EHR adoption 50
5.2.1.2 Growing venture capital investments 51
5.2.1.3 Growing pressure to curb healthcare spending and improve patient outcomes 52
5.2.1.4 Big data in healthcare 54
5.2.1.5 Launch of new/upgraded healthcare analytics solutions and services 54
5.2.2 RESTRAINTS 55
5.2.2.1 Dearth of skilled personnel 55
5.2.2.2 High cost of analytics solutions 55
5.2.3 OPPORTUNITIES 55
5.2.3.1 Increasing focus on value-based medicine 55
5.2.3.2 Use of analytics in precision and personalized medicine 56
5.2.3.3 Cloud-based analytics 57
5.2.3.4 Increasing number of patient registries 57
5.2.3.5 Emergence of social media and its impact on the healthcare industry 58
5.2.4 CHALLENGES 58
5.2.4.1 Patient data confidentiality 58
5.2.4.2 Concerns regarding inaccurate and inconsistent data 58
5.2.4.3 Reluctance to adopt healthcare analytics in emerging countries 59
5.2.4.4 Data integration 59
5.2.4.5 Operational gaps between payers and providers 59
6 HEALTHCARE ANALYTICS MARKET, BY TYPE 60
6.1 INTRODUCTION 61
6.2 DESCRIPTIVE ANALYTICS 62
6.3 PREDICTIVE ANALYTICS 65
6.4 PRESCRIPTIVE ANALYTICS 69
7 HEALTHCARE ANALYTICS MARKET, BY COMPONENT 73
7.1 INTRODUCTION 74
7.2 SERVICES 75
7.2.1 SUPPORT SERVICES 78
7.2.2 BUSINESS ANALYTICS SERVICES 81
7.3 SOFTWARE 83
7.4 HARDWARE 86
 
8 HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL 89
8.1 INTRODUCTION 90
8.2 ON-PREMISE HEALTHCARE ANALYTICS 91
8.3 ON-DEMAND HEALTHCARE ANALYTICS 94
9 HEALTHCARE ANALYTICS MARKET, BY APPLICATION 98
9.1 INTRODUCTION 99
9.2 FINANCIAL ANALYTICS 100
9.2.1 CLAIMS PROCESSING 104
9.2.2 REVENUE CYCLE MANAGEMENT (RCM) 107
9.2.3 PAYMENT INTEGRITY AND FRAUD, WASTE, AND ABUSE (FWA) 110
9.2.4 RISK ADJUSTMENT AND RISK ASSESSMENT 113
9.3 CLINICAL ANALYTICS 116
9.3.1 QUALITY IMPROVEMENT AND CLINICAL BENCHMARKING 121
9.3.2 CLINICAL DECISION SUPPORT 124
9.3.3 REGULATORY REPORTING AND COMPLIANCE 127
9.3.4 COMPARATIVE ANALYTICS/ EFFECTIVENESS 129
9.3.5 PRECISION HEALTH 132
9.4 OPERATIONAL AND ADMINISTRATIVE ANALYTICS 135
9.4.1 SUPPLY CHAIN ANALYTICS 139
9.4.2 WORKFORCE ANALYTICS 142
9.4.3 STRATEGIC ANALYTICS 145
9.5 POPULATION HEALTH ANALYTICS 147
9.5.1 APPLICATIONS OF POPULATION HEALTH ANALYTICS 150
9.5.1.1 Population risk management 150
9.5.1.2 Population care management 150
9.5.1.3 Patient engagement 150
9.5.1.4 Clinical outcome management 151
9.5.1.5 Activity-based costing 151
9.5.2 MARKET DRIVERS FOR POPULATION HEALTH ANALYTICS 151
9.5.2.1 Rising number of accountable care organizations 151
9.5.2.2 Increasing costs of chronic disease treatment 151
9.5.2.3 Initiatives for population health management 152
9.5.3 MARKET RESTRAINTS FOR POPULATION HEALTH ANALYTICS 152
9.5.3.1 Lack of data management capabilities and skilled analysts 152
 
10 HEALTHCARE ANALYTICS MARKET, BY END USER 153
10.1 INTRODUCTION 154
10.2 PAYERS 155
10.2.1 PRIVATE INSURANCE COMPANIES 159
10.2.2 GOVERNMENT AGENCIES 161
10.2.3 EMPLOYERS AND PRIVATE EXCHANGES 164
10.3 PROVIDERS 166
10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS 170
10.3.2 POST-ACUTE CARE ORGANIZATIONS 173
10.3.3 AMBULATORY SETTINGS 176
10.4 ACOS, HIES, MCOS, AND TPAS 179
11 HEALTHCARE ANALYTICS MARKET, BY REGION 183
11.1 INTRODUCTION 184
11.2 NORTH AMERICA 184
11.2.1 US 192
11.2.2 CANADA 198
11.3 EUROPE 205
11.3.1 GERMANY 213
11.3.2 UK 219
11.3.3 FRANCE 225
11.3.4 REST OF EUROPE 231
11.4 ASIA 237
11.4.1 JAPAN 245
11.4.2 CHINA 251
11.4.3 INDIA 257
11.4.4 REST OF ASIA 263
11.5 PACIFIC COUNTRIES 269
11.6 LATIN AMERICA 275
11.7 MIDDLE EAST AND AFRICA 281
12 COMPETITIVE LANDSCAPE 288
12.1 OVERVIEW 288
12.2 MARKET RANK ANALYSIS 290
12.3 COMPETITIVE SCENARIO 292
12.3.1 PARTNERSHIPS, AGREEMENTS, COLLABORATIONS, AND ALLIANCES 292
12.3.2 PRODUCT AND SERVICE LAUNCHES, PRODUCT UPGRADES, AND PRODUCT ENHANCEMENTS 293
12.3.3 ACQUISITIONS 294
12.3.4 EXPANSIONS 295
 
13 COMPANY PROFILES 296
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
13.1 ALLSCRIPTS HEALTHCARE SOLUTIONS 296
13.2 CERNER 302
13.3 HEALTH CATALYST 306
13.4 IBM 311
13.5 INOVALON 316
13.6 MCKESSON 319
13.7 MEDEANALYTICS 323
13.8 OPTUM 326
13.9 ORACLE 331
13.10 SAS INSTITUTE 335
13.11 SCIO HEALTH ANALYTICS 339
13.12 VERSCEND TECHNOLOGIES 342
13.13 CITIUSTECH 344
13.14 WIPRO 347
13.15 VITREOSHEALTH 350
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.
14 APPENDIX 352
14.1 INSIGHTS FROM INDUSTRY EXPERTS 352
14.2 DISCUSSION GUIDE 353
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 357
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 359
14.5 AVAILABLE CUSTOMIZATIONS 360
14.6 RELATED REPORTS 361
14.7 AUTHOR DETAILS 362